j_asam-2020-005_tab_001
| Recurrence | Major bleed | |
|---|---|---|
| Rivaroxaban 10mg od | 1.2% | 0.4% |
| Rivaroxaban 20mg od | 1.5% | 0.5% |
| Aspirin 100mg od | 4.4% | 0.4% |
| Apixaban 2.5mg bd | 1.7% | 0.2% |
| Apixaban 5mg bd | 1.7% | 0.1% |
| Placebo | 8.8% | 0.5% |
Language: English
Page range: 1 - 6
Published on: Jan 29, 2021
Published by: Australasian Society of Aerospace Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Related subjects:
© 2021 Rachel MacKellar, published by Australasian Society of Aerospace Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.